27 Jan 2023 --- The US Food and Drug Administration (FDA) has said no to three different citizen petitions requesting that cannabidiol (CBD) products be marketed as dietary supplements. The groups behind the requests are the Consumer Healthcare Products Association (CHPA), the Council for Responsible Nutrition (CRN) and the Natural Products Association (NPA).
.jpeg)
